1st Quarter - Report

EMD SERONO, INC. for EMD SERONO INC

Firm
Client
Income
—
Expenses
$470,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

HR 1: For the People Act of 2019; provisions related to the DISCLOSE Act

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) New Intern, Senate Majority Leader Bill Frist, 2004-2005; Senate Doorkeeper, 2005.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (116th)

Chemicals/Chemical Industry CHM

General discussions regarding the Toxic Substances Control Act (TSCA) - Section 5

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) New Intern, Senate Majority Leader Bill Frist, 2004-2005; Senate Doorkeeper, 2005.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Animals ANI

General Discussions regarding the Food and Drug Administration's Predictive Toxicology Roadmap

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) New Intern, Senate Majority Leader Bill Frist, 2004-2005; Senate Doorkeeper, 2005.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Discussions regarding the United States-Mexico-Canada Agreement Discussions regarding Section 301 and Section 232 tariffs Discussions regarding the United States-European Union Free Trade Agreement Discussions regarding the United States-Switzerland Free Trade Agreement

LobbyistCovered position, as disclosed
STEPHANIE FRYE (FORMERLY SALVAGNO) New Intern, Senate Majority Leader Bill Frist, 2004-2005; Senate Doorkeeper, 2005

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

HR 1: For the People Act of 2019; issues related to DISCLOSE/FARA provisions and healthcare provisions HR 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill HR 1046: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S.377 - Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill General Discussions regarding healthcare General Discussions regarding the Trump Administration's American Patients First blueprint General Discussions regarding the Department of Health and Human Services proposed rebate rule

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —
THOMAS CORDREY ROBERGE New Legislative Counsel - U.S. Senator Peter G. Fitzgerald (2002-2004)
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 377 (116th), H.R. 1 (116th), H.R. 1046 (116th), H.R. 965 (116th)

Medicare/Medicaid MMM

HR 1046: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill S 377: Medicare Negotiation and Competitive Licensing Act of 2019; all provisions of the bill General discussions regarding Medicare reimbursement General discussions regarding Health and Human Services proposed rebate rule

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —
THOMAS CORDREY ROBERGE New Legislative Counsel - U.S. Senator Peter G. Fitzgerald (2002-2004)
WENDY SUSSMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1046 (116th)

Pharmacy PHA

HR 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions of the bill HR 1034: Phair Pricing Act of 2019; all provisions of the bill HR 1035: Prescription Drug Price Transparency Act; all provisions of the bill HR 1423: Forced Arbitration Injustice Repeal (FAIR) Act; all provisions of the bill S 474: Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019; all provisions of the bill S 476: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019 ; all provisions of the bill General discussions regarding pharmaceutical issues General discussions regarding the Department of Health and Human Service proposed rebate rule

LobbyistCovered position, as disclosed
MALLORI ANNE MERANDINO —
THOMAS CORDREY ROBERGE New Legislative Counsel - U.S. Senator Peter G. Fitzgerald (2002-2004)
WENDY SUSSMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1423 (116th), H.R. 1035 (116th), H.R. 965 (116th), H.R. 1034 (116th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
MERCK HOLDINGS (CHINA) CO., LTD. China China — —

Affiliated organisations

OrganisationLocation
EMD MILLIPORE CORPORATION Burlington, MA, US
EMD PERFORMANCE MATERIALS Philadelphia, PA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.